Y Intercept (Hong Kong) LTD I Teos Therapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$10.33 - $18.09 $215,008 - $376,525
20,814 New
20,814 $308,000
Q4 2023

Feb 13, 2024
SELL
$8.57 - $11.06 $42 - $55
-5 Reduced 0.02%
26,430 $289,000
Q3 2023

Nov 14, 2023
BUY
$10.95 - $14.6 $289,463 - $385,951
26,435 New
26,435 $289,000
Q1 2023

May 09, 2023
BUY
$13.02 - $22.62 $6,952 - $12,079
534 Added 4.1%
13,573 $184,000
Q4 2022

Feb 14, 2023
BUY
$17.77 - $21.6 $231,703 - $281,642
13,039 New
13,039 $254,000

Others Institutions Holding ITOS

# of Institutions
166
Shares Held
36.6M
Call Options Held
1.95M
Put Options Held
374K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $257M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email